US FDA clears Life Spine’s Plateau-C Ti cervical spacer system

81

The US Food and Drug Administration (FDA) has given 510(k) market clearance to Life Spine’s Plateau-C Ti cervical spacer system.

The system utilises the company’s proprietary titanium surface technology, Osseo-Loc, a surface technology designed to help create an environment for potential bone growth. Additionally, in comparison to its PEEK counter-part, Plateau-C Ti offers additional graft windows for increased visibility in-situ and bone graft containment.

Plateau-C Ti entered a full market release on April 3, 2017.